BIOMAT Database Logo BIOMAT Database Logo

Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes. 2018

Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Department of Internal Medicine, Chungnam National University School of Medicine, 266 Munwha-ro, Jung-gu, Daejeon 35015, Republic of Korea.

We analyzed circulating Meteorin-like (METRNL) levels in human. Serum METRNL levels were significantly lower in subjects with diabetes mellitus compared with those without diabetes. Serum METRNL was negatively correlated with the serum glucose level and insulin resistance. Metformin treatment did not increase the serum METRL levels after 12 weeks.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008687 Metformin A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) Dimethylguanylguanidine,Dimethylbiguanidine,Glucophage,Metformin HCl,Metformin Hydrochloride,HCl, Metformin,Hydrochloride, Metformin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D036341 Intercellular Signaling Peptides and Proteins Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal. Growth Factor,Growth Factors,Paracrine Peptide Factors,Paracrine Protein Factors,Factor, Growth,Factors, Growth,Peptide Factors, Paracrine

Related Publications

Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Comparison of plasma and salivary meteorin-like protein levels in patients with newly diagnosed Type-2 diabetes and treated with metformin.
October 2022, European review for medical and pharmacological sciences,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance.
March 2019, Medical science monitor : international medical journal of experimental and clinical research,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Circulating Meteorin-like Levels in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis.
January 2020, Current pharmaceutical design,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
IL-18 Serum Levels in Patients with Obesity, Prediabetes and Newly Diagnosed Type 2 Diabetes.
June 2022, Iranian journal of immunology : IJI,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
April 2021, Diabetes therapy : research, treatment and education of diabetes and related disorders,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes.
January 2016, Journal of diabetes and its complications,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Elevated serum Meteorin-like levels in patients with hyperthyroidism.
December 2022, BMC endocrine disorders,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients.
January 2015, Platelets,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Serum fetuin-A concentrations are positively associated with serum VEGF levels in patients with newly diagnosed type 2 diabetes.
January 2015, Endocrine journal,
Ju Hee Lee, and Yea Eun Kang, and Ji Min Kim, and Sorim Choung, and Kyong Hye Joung, and Hyun Jin Kim, and Bon Jeong Ku
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients.
November 2014, Diabetes research and clinical practice,
Copied contents to your clipboard!